-
1
-
-
70349966234
-
Pathophysiology, diagnosis and management of postoperative dumping syndrome
-
Tack J, Arts J, Caenepeel P, De Wulf D, Bisschops R. Pathophysiology, diagnosis and management of postoperative dumping syndrome. Nat Rev Gastroenterol Hepatol 2009; 6:583-90.
-
(2009)
Nat Rev Gastroenterol Hepatol
, vol.6
, pp. 583-590
-
-
Tack, J.1
Arts, J.2
Caenepeel, P.3
De Wulf, D.4
Bisschops, R.5
-
2
-
-
69249211012
-
Successful medical management of status post-roux-en-y-gastric-bypass hyperinsulinemic hypoglycemia
-
Spanakis E, Gragnoli C. Successful medical management of status post-roux-en-y-gastric-bypass hyperinsulinemic hypoglycemia. Obes Surg 2009; 19:1333-4.
-
(2009)
Obes Surg
, vol.19
, pp. 1333-1334
-
-
Spanakis, E.1
Gragnoli, C.2
-
3
-
-
37249068476
-
Dumping syndrome presenting three decades after vagotomy
-
Patton C, Okosieme OE, Evans LM. Dumping syndrome presenting three decades after vagotomy. New Zealand Medical J 2007; 120(1265):2807.
-
(2007)
New Zealand Medical J
, vol.120
, Issue.1265
, pp. 2807
-
-
Patton, C.1
Okosieme, O.E.2
Evans, L.M.3
-
4
-
-
62349118969
-
Evaluation and management of adult hypoglycemic disorders: an endocrine society clinical practice guideline
-
Cryer PE, Axelrod L, Grossman AB, Heller SR, Montori VM, Seaquist ER, et al. Evaluation and management of adult hypoglycemic disorders: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2009; 94:709-28.
-
(2009)
J Clin Endocrinol Metab
, vol.94
, pp. 709-728
-
-
Cryer, P.E.1
Axelrod, L.2
Grossman, A.B.3
Heller, S.R.4
Montori, V.M.5
Seaquist, E.R.6
-
5
-
-
0034849950
-
Postprandial GLP-1, norepinephrine, and reactive hypoglycemia in dumping syndrome
-
Gebhard B, Holst JJ, Biegelmayer C, Miholic J. Postprandial GLP-1, norepinephrine, and reactive hypoglycemia in dumping syndrome. Digestive Diseases Sci 2001; 46:1915-23.
-
(2001)
Digestive Diseases Sci
, vol.46
, pp. 1915-1923
-
-
Gebhard, B.1
Holst, J.J.2
Biegelmayer, C.3
Miholic, J.4
-
6
-
-
0031721391
-
Exaggerated secretion of glucagon-like peptide-1 (GLP-1) could cause reactive hypoglycaemia
-
Toft-Nielsen M, Madsbad S, Holst JJ. Exaggerated secretion of glucagon-like peptide-1 (GLP-1) could cause reactive hypoglycaemia. Diabetologia 1998; 41:1180-6.
-
(1998)
Diabetologia
, vol.41
, pp. 1180-1186
-
-
Toft-Nielsen, M.1
Madsbad, S.2
Holst, J.J.3
-
8
-
-
11844294865
-
A-Glucosidase inhibitors for patients with type 2 diabetes: results from a Cochrane systematic review and meta-analysis
-
Van De Laar FA, Lucassen PL, Akkermans RP, Van De Lisdonk EH, Rutten GE, Van Weel C. A-Glucosidase inhibitors for patients with type 2 diabetes: results from a Cochrane systematic review and meta-analysis. Diabetes Care 2005; 28:154-63.
-
(2005)
Diabetes Care
, vol.28
, pp. 154-163
-
-
Van De Laar, F.A.1
Lucassen, P.L.2
Akkermans, R.P.3
Van De Lisdonk, E.H.4
Rutten, G.E.5
Van Weel, C.6
-
9
-
-
62849090740
-
Efficacy of the long-acting repeatable formulation of the Somatostatin analogue Octreotide in postoperative dumping
-
Arts J, Caenepeel P, Bisschops R, Dewulf D, Holvoet L, Piessevaux H, et al. Efficacy of the long-acting repeatable formulation of the Somatostatin analogue Octreotide in postoperative dumping. Clinical Gastroenterol Hepatol 2009; 7:432-7.
-
(2009)
Clinical Gastroenterol Hepatol
, vol.7
, pp. 432-437
-
-
Arts, J.1
Caenepeel, P.2
Bisschops, R.3
Dewulf, D.4
Holvoet, L.5
Piessevaux, H.6
-
10
-
-
0026681433
-
Assessment of gall bladder dynamics, cholecystokinin release and the development of gallstones during octreotide therapy for acromegaly
-
Ewins DL, Javaid A, Coskeran PB, Shah S, Butler J, Deprez PH, et al. Assessment of gall bladder dynamics, cholecystokinin release and the development of gallstones during octreotide therapy for acromegaly. Quarterly J Med 1992; 83:295-306.
-
(1992)
Quarterly J Med
, vol.83
, pp. 295-306
-
-
Ewins, D.L.1
Javaid, A.2
Coskeran, P.B.3
Shah, S.4
Butler, J.5
Deprez, P.H.6
-
11
-
-
0014410629
-
Diazoxide and the treatment of hypoglycemia: an historical review
-
Black J. Diazoxide and the treatment of hypoglycemia: an historical review. Ann NY Acad Sci 1968; 150:194-203.
-
(1968)
Ann NY Acad Sci
, vol.150
, pp. 194-203
-
-
Black, J.1
-
12
-
-
0014410649
-
The therapeutic application of diazoxide in pediatric hypoglycemic states
-
Drash A, Kenny F, Field J, Blizzard R, Langs H, Wolff F. The therapeutic application of diazoxide in pediatric hypoglycemic states. Ann NY Acad Sci 1968; 150:337-55.
-
(1968)
Ann NY Acad Sci
, vol.150
, pp. 337-355
-
-
Drash, A.1
Kenny, F.2
Field, J.3
Blizzard, R.4
Langs, H.5
Wolff, F.6
-
13
-
-
0030695334
-
Diazoxide treatment for insulinoma: a national UK survey
-
Gill GV, Rauf O, MacFarlane IA. Diazoxide treatment for insulinoma: a national UK survey. Postgraduate Med J 1997; 73:640-1.
-
(1997)
Postgraduate Med J
, vol.73
, pp. 640-641
-
-
Gill, G.V.1
Rauf, O.2
MacFarlane, I.A.3
-
14
-
-
79958118313
-
Current understanding of KATP channels in neonatal diseases: focus on insulin secretion disorders
-
Quan Y, Barszczyk A, Feng ZP, Sun HS. Current understanding of KATP channels in neonatal diseases: focus on insulin secretion disorders. Acta Pharmacologica Sinica 2011; 32:765-80.
-
(2011)
Acta Pharmacologica Sinica
, vol.32
, pp. 765-780
-
-
Quan, Y.1
Barszczyk, A.2
Feng, Z.P.3
Sun, H.S.4
-
15
-
-
57149083860
-
The incretins: from the concept to their use in the treatment of type2 diabetes. Part A: Incretins: concept and physiological functions
-
Girard J. The incretins: from the concept to their use in the treatment of type2 diabetes. Part A: Incretins: concept and physiological functions. Diabetes Metab 2008; 34:550-9.
-
(2008)
Diabetes Metab
, vol.34
, pp. 550-559
-
-
Girard, J.1
|